Complaint
Treatment of Vitamin B1 Deficiency CAS 22457-89-2 Benfotiamine Powder
Product Description:
Benfotiamine is vitamin B1 fat soluble derivatives, improve the bioavailability of water-soluble vitamin B1 low shortcomings, improve the blood and tissue concentrations of thiamine, so as to improve the curative effect.
Benfotiamine is primarily marketed as an antioxidant dietary supplement. In a clinical study with six patients, benfotiamine lowered AGE by 40%.
Function:
Benfotiamine is useful for the treatment of diabetic retinopathy, neuropathy, and nephropathy however "Most of the effects attributed to benfotiamine are extrapolated from in vitro and animal studies. Unfortunately apparent evidences from human studies are scarce and especially endpoint studies are missing. Therefore additional clinical studies are mandatory to explore the therapeutic potential of benfotiamine in both diabetic and non-diabetic pathological conditions".
It is thought that treatment with benfotiamine leads to increased intracellularthiamine diphosphate levels, a cofactor of transketolase. This enzyme directs advanced glycation and lipoxidation end products (AGE's, ALE's) substrates to the pentose phosphate pathway, thus reducing tissue AGEs.
Application Area:
1. Benfotiamine is used for the prevention and treatment of vitamin B1 deficiency;
2. For vitamin B1 demand increase, with inadequate intake from foods supplies (fatigue, hyperthyroidism, pregnancy, lactation, during strenuous manual labor, etc.);
3. Benfotiamine is used in the treatment of non alcoholic wernicke encephalopathy;
4. To treat beriberi;
5. Used in the following diseases, speculation and vitamin B1 deficiency and metabolic disorders associated with treatment, such as: neuralgia; Muscle pain, joint pain; Peripheral neuritis, peripheral nerve palsy; Myocardial metabolic disorders; Constipation and other gastrointestinal motor function obstacle.
FAQ
Application Area:
Uridine 5-Mophosphate Disodium are produced through the hydrolytic reaction from Ribonucleic acid(RNA) as raw material by enzymatic catalysis to form four kinds of nucleotides 5- 'AMP (adenosine-5'-monophosphate), 5'-GMP•2Na(guanosine-5'-monophosphate, disodium salt), 5'-CMP(cytidine-5'-monophosphate)-, 5'-UMP•2Na (uridine- 5'-monophosphate,Disodium salt) .By the chromatographic isolation, four kinds of separated 5'-nucleotide products with high purity can be obtained. These products can be widely applied in medicine, reagent, fine chemical industry, and additive of food fields etc.
1. Benfotiamine powder is used for the prevention and treatment of vitamin B1 deficiency;
2. For vitamin B1 demand increase, with inadequate intake from foods supplies (fatigue, hyperthyroidism, pregnancy, lactation, during
strenuous manual labor, etc.);
3. Benfotiamine is used in the treatment of nonalcoholic wernicke encephalopathy;
4. To treat beriberi;
5. Used in the following diseases, speculation, and vitamin B1 deficiency and metabolic disorders associated with treatment, such as:
neuralgia; Muscle pain, joint pain; Peripheral neuritis, peripheral nerve palsy; Myocardial metabolic disorders; Constipation and other
gastrointestinal motor function obstacle.
Test Item | Analysis Specification | Result |
Description | White to almost white crystal | White to almost white crystal |
Identification | A: IR spectra shows the similarity between sample and standard B: The retention time of the major peak corresponds with it of the reference standard | Complies Complies |
Solution color and clearness | Colorless to a pale yellow clear solution | Complies |
Chlorides | Not more than 0.053% | <0.053% |
Sulphate | Not more than 0.011% | <0.011% |
Loss on drying | Not more than 1.5% | 0.66% |
Heavy metals | Not more than 0.002% | <0.002% |
Related Substances | TMP :Not more than 0.15% Benzoic acid: not more than0.1% Amide: not more than 0.40% Single unknown impurity: not more than0.1% Thiamine: not more than0.1% Total impurities: Not more than 1.5% | <0.025% No detectable 0.06% 0.08% No detectable 0.33% |
Residual solvents | Dichloromethane: not more than 600ppm Isopropanol: not more than300ppm | No detectable 64ppm |
Microbial limits | Total bacteria: not more than100cfu/g Yeast and mold: not more than50cfu/g Escherichia coli: no detectable | <10 cfu/g <10 cfu/g No detectable |
Assay(Dry Basis) | 98.0%~102.0% | 99.6% |
Conclusion | Complies with company Standard. | |
